Page 1 - I. Chemical biology and drug discovery
P. 1

Target deconvolution using label-free method of autophagy inhibitor and its antitumor activity in
               glioblastoma
               Hui-Yun Hwang , Yoon Sun Cho , Jin Young Kim , Ki Na Yun , Jong Shin Yoo , Eunhyeong Lee , Injune Kim , György Marko-Varga 1,4  and Ho Jeong Kwon *
                                                 2
                                                                            3
                                                                    3
                                                          2
                                 1
                        1
                                                                                                      1
                                          2
               1 Chemical Genomics Global Research Laboratory, Department of Biotechnology, College of Life Science & Biotechnology, Yonsei University, Seoul 120-749, Korea  2 Biomedical Omics
               Group, Korea Basic Science Institute, Ochang, Chungbuk 28119, Korea  3 Biomedical Science and Engineering Interdisciplinary Program, Korea Advanced Institute of Science and
               Technology, Daejeon, Korea  4 Clinical Protein Science & Imaging, Department of Biomedical Engineering, Lund University, BMC D13, SE-221 84 Lund, Sweden
               *Corresponding author: kwonhj@yonsei.ac.kr
                   BACKGROUND                                                  AIM
    Manipulating autophagy is a promising strategy for treating cancer as  To identify protein targets and uncover the unknown mechanisms
   several autophagy inhibitors are shown to induce autophagic cell death.  of APZ, we used a label-free drug affinity responsive target stability
                                                          (DARTS) approach with a liquid chromatography/tandem mass
   One of these, autophagonizer (APZ), induces apoptosis-independent  spectrometry  (LC–MS/MS)  readout.  Collectively,  our  study
   cell death by binding an unknown target via an unknown mechanism in  demonstrated that APZ, a new autophagy inhibitor, can be used as
   vitro & in vivo. We identified Hsp70 as a key target protein of unmodified  a potent antitumor drug candidate to get over unassailable glioma
   APZ in autophagy.                                      and revealed a novel function of Hsp70 in lysosomal integrity
                                                          regulation of autophagy.
                                                METHODS
    Combined drug affinity responsive target stability (DARTS) and LC−MS/MS method
   identified a new protein target of APZ. (1) Exposure of the small molecule to proteins
   in the cell lysate proteome pool, to allow for small molecule–protein target
   interactions, (2) pronase digestion of proteins unprotected by the small molecule,
   where proteins that bind resist protease treatment while proteins with little or no
   binding to the small molecule are degraded, (3) further proteolysis with trypsin and
   LC–MS/MS analysis of resulting peptides to determine sequence coverage, (4)
   identification of proteins protected by the small molecule based on its enhanced
   sequence coverage by more than 3% compared to controls, and (5) selection of likely
   protein targets based on candidates with phenotypic relevancy to the small molecule.

                                                RESULTS
   Figure 1. APZ works not by inducing      Figure 1  Electromicroscopy         Double-tagged LC3 transfection
   autophagy, but by inhibiting autophagy
   Figure 2. Characterization of Hsp70 as a
   potential protein target of APZ

   Figure 3. APZ exhibits significant
   synergism with TMZ in orthotopic mouse
   xenograft model                                  Red arrow: autophagosomes  Flux (X)      ★ Rapa: autophagy inducer
                                                    Black arrow: autolysosomes  Flux (O)     ★ HeLa cells

   Figure 2  Peptide analysis detected in DARTS LC-MS   DARTS biophysical validation  Figure 3











                                                                                                  GFP-GL261 cells







          CONCLUSION                         REFERENCES                   ACKNOWLEDGEMENTS

                                                                          Supported  by  BK21  PLUS,  NRF  (MSIP;
    Collectively, our study showed that both APZ  [1] Hwang HY, Cho YS, Kim JY, Yun KN, Yoo JS, Lee E, et al.  2015K1A1A2028365,2018M3A9C4076477,
                                      Autophagic Inhibition via Lysosomal Integrity Dysfunction
   treatment  and  orthogonal  Hsp70  inhibition  Leads to Antitumor Activity in Glioma Treatment. Cancers  2016K2A9A1A03904900)
   increased specific markers of autophagy to form  2020; 12.
   autophagosomes. In addition to the role of APZ as  [2] Choi IK, Cho YS, Jung HJ, Kwon HJ. Autophagonizer, a
   a specific inhibitor of Hsp70, we also revealed a  novel synthetic small molecule, induces autophagic cell death.  Contact information
                                      Biochemical and biophysical research communications 2010;
   new functional role of Hsp70 in autophagosome  393:849-854.
   formation and induction of incomplete lysosomes  [3] Kim D, Hwang HY, Kwon HJ. Targeting Autophagy In  •  Presenter: Hui-Yun Hwang
   leading to autophagic cell death in cancer cells.  Disease: Recent Advances In Drug Discovery. Expert opinion
   This novel role of Hsp70 likely involves the  on drug discovery 2020; 15:1045-1064.  ghkdgmldbs@naver.com
   stabilization of lysosomes based on pH integrity                      •  Coresspondence: Ho Jeong Kwon
   and suggests a mechanism for its action.  .
                                                                            kwonhj@yonsei.ac.kr  Presenter  :
                                                                         Minjeong Ko
   1   2   3   4   5   6